Products

• OWLiver

User Password

• Forgot your password?
• Request registry

OWLiver - Posters

• Serum-based Metabolomics-Advanced StEatohepatitis Fibrosis Score (MASEF) fot the non-invasive identification of patients with non-alcoholic steatohepatitis with significant fibrosis

  M. Noureddin, et al.

  Poster presented at the Digital International Liver CongressTM 2020 of the European Association for the Study of the Liver (EASL), August 17-29.

• Application of a Non-Invasive Integrated Screening Approach to Facilitate Enrollment of Clinical Trials with Investigational NAFLD/NASH Therapeutics

  G. Rodriguez-Araujo, et al.

  Poster presented at the First EASL Nonalcoholic Fatty Liver Disease (NAFLD) Summit: "Target-oriented approach to Diagnosis and Pharmacotherapy of Nonalcoholic Steatohepatitis (NASH), a dialogue between Academia and Industry", Rome, November 9-11.

• Clinical validation of a non-invasive lipidomic test for the diagnosis of non-alcoholic fatty liver disease (NAFLD)

  P. Salvador et al.

  Poster presented at the International Liver Congress, the annual meeting of the European Association for the Study of the Liver (EASL), Barcelona, April 13-17.

• Development of A Non-Invasive Companion Diagnostic Program for Non-Alcoholic steatohepatitis

  P. Ortiz et al.

  Poster presented at the 6th Annual World CDx Congress by Angel Santos. Boston, Massachusetts (USA) September 8-11, 2015.

• Incidence of non-alcoholic fatty liver disease in non-obese and non-diabetic individuals during normal aging

  P. Ortiz et al.

  Poster presented at the AASLD. Industry Colloquium: Novel Targets and Therapies in Liver Disease, Durham, North Carolina. March 20-21, 2015.

• Prevalence of nonalcoholic fatty liver disease and its association with aging

  A. Cano et al.

  Poster presented at the Liver Meeting 2014 by Dr. Rebeca Mayo, Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Boston, Massachusetts (USA) November 7-8.
  

• Non-invasive Lipidomics test for improving assessment of NAFLD: Clinical patients diagnosis and follow-up

  A. Castro et al.

  Poster presented at the XXIII Congress of the Latin American Association for the Study of the Liver, Cancun, Mexico, 11-13 September 2014; organized by ALEH, Asociación Latinoamericana para el Estudio del Hígado.
  

• Understanding lipid fluxes in nonalcoholic fatty-liver disease through lipidomics

  M. Pérez-Cormenzana et al.

  Poster presented at Lipid Pathways in Biology and Disease, Dublin, Ireland, March, 19-24th 2014; organized by Keystone Symposia on Molecular and Cellular Biology and Science Foundation Ireland.
  

• Signature lipid biomarker analysis of non-alcoholic liver disease

  C. Alonso et al.

  Poster presented at 9th annual Conference of the Metabolomics Society. Glasgow, July, 1-4, 2013.

• The signature biomarker lipids of NASH and identification of a novel pathway for hepatic triglyceride synthesis

  C. Alonso et al.

  Poster presented at LIPID MAPS Annual Meeting 2013: Impact of Lipidomics on Oxidized Lipids and Non-Alcoholic Fatty Liver Disease. La Jolla, CA, May 7-8, 2013.

• Metabolic profiling as a noninvasive tool for nonalcoholic steatohepatitis diagnosis

  J. Barr et al.

  Poster presented at the Liver Meeting 2011, the 62nd Annual Meeting of the American Association for the Study of Liver Diseases, San Francisco (EEUU) 4-8 November, 2011.

• The development of metabolome-based predictors of nonalcoholic fatty liver disease

  J. Barr et al.

  Poster presented at the 7th Annual Advances in Metabolic Profiling conference and exhibition, Dublin (Ireland) 8-9 November, 2011.

• Metabolic profiling as a non-invasive tool for non-alcoholic steatohepatitis diagnosis

  J. Barr et al.

  Poster presented at Metabomeeting, Lyon (France) 28-29 April 2008.

• Metabolic profiling as a non-invasive tool for non-alcoholic steatohepatitis diagnosis

  J. Barr et al.

  Poster presented at EASL NAFLD meeting, Bologna (Italy) 24- 26 September 2009.

• Serum metabolic profiling reveals novel biomarkers associated with NAFLD progression

  M. Vázquez-Chantada et al.

  Poster presented at: International Liver Congress 2010 by EASL, in Vienna, Austria, April 14-18, 2010.

• 
  • Description
  • Benefits
  • Download brochure
• 
  • How it works
  • FAQs
  • Publications
  • Posters
  • Patents
  • Leading organizations in Fatty Liver Disease
  • Information form
  • OWLiver application form
• 
  • FAQs
  • Hepatic diseases
  • Leading organizations in Fatty Liver Disease